All stocks ยท KABRADG
KD

Kabra Drugs Ltd

KABRADG BSE Drug Manufacturers - Specialty & Generic Healthcare

Aanjaay Industries Limited does not have significant operations. Previously, the company was engaged in permaculture manufacturing and trading of pharma related products. Aanjaay Industries Limited was formerly kown as โ€ฆ

ISIN INE323K01017
Listed โ€”
Quarters tracked 13
Filings 20 docs

About

Aanjaay Industries Limited does not have significant operations. Previously, the company was engaged in permaculture manufacturing and trading of pharma related products. Aanjaay Industries Limited was formerly kown as Kabra Drugs Limited and changed its name to Aanjaay Industries Limited in July 2026. The company was incorporated in 1989 and is based in Chennai, India.

Key Metrics

as of Sep 2026
Market Cap47 Cr
P/E6.24
Div Yield0.00 %
Book Valueโ‚น12.50
52w Highโ‚น35.50
52w Lowโ‚น15.50
Face Valueโ‚น10.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 46.22 35.41 30.42 19.76 7.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 43.43 34.07 27.99 17.72 7.67 0.24 0.53 0.40 0.55 0.37 0.11 0.13 0.12
Operating Profit 2.79 1.34 2.43 2.04 -0.52 -0.24 -0.53 -0.40 -0.55 -0.37 -0.11 -0.13 -0.12
OPM % 6.04 3.78 7.99 10.32 -7.27 โ€” โ€” โ€” โ€” โ€” โ€” โ€” โ€”
Other Income 0.08 0.11 0.18 0.18 0.02 0.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.02 0.02 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 2.84 1.42 2.60 2.21 -0.50 0.39 -0.53 -0.40 -0.55 -0.37 -0.11 -0.13 -0.12
Tax % 25.35 25.35 1.54 16.74 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit 2.12 1.06 2.57 1.84 -0.50 0.39 -0.54 -0.40 -0.55 -0.37 -0.11 -0.13 -0.12
EPS in Rs 0.89 0.45 1.08 0.78 -0.21 0.16 -0.54 -0.40 -1.25 -0.84 -0.25 -0.30 -0.27

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 93.000.000.000.000.000.000.000.002.008.0010.008.00
Expenses 87.002.001.000.000.000.000.000.003.007.009.008.00
Operating Profit 5.00-2.00-1.000.000.000.000.000.00-1.000.000.000.00
OPM % 6.00โ€”โ€”-3,400.00โ€”โ€”-150.00โ€”-57.006.004.706.00
Other Income 0.001.000.000.000.000.000.000.00-1.000.000.000.00
Interest 0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation 0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax 6.00-1.00-1.000.000.000.000.000.00-2.000.000.000.00
Tax % 13.000.000.000.000.000.000.000.000.007.0040.0036.00
Net Profit 5.00-1.00-1.000.000.000.000.000.00-2.000.000.000.00
EPS in Rs 2.09-0.46-1.69-0.77-0.43-0.41-0.14-0.36-5.380.300.070.16
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 24.0024.004.004.004.004.004.004.004.004.004.004.00
Reserves 6.001.00-3.00-5.00-5.00-5.00-4.00-4.00-4.00-2.00-2.00-2.00
Borrowings 1.000.002.001.001.001.001.001.001.002.002.003.00
Other Liabilities 56.000.002.000.000.001.001.001.001.002.004.003.00
Total Liabilities 86.0025.005.001.001.001.001.001.002.006.009.009.00
Fixed Assets 1.000.000.000.000.000.000.000.000.002.003.003.00
CWIP 0.000.000.000.000.000.000.000.000.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 85.0025.005.001.001.001.001.001.002.004.006.006.00
Total Assets 86.0025.005.001.001.001.001.001.002.006.009.009.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity -9.00-5.000.000.000.000.000.000.000.000.000.000.00
Cash from Investing Activity -1.000.000.000.000.000.000.000.002.000.000.000.00
Cash from Financing Activity 0.0023.003.000.000.000.000.000.00-1.000.000.001.00
Net Cash Flow -11.0019.003.000.000.000.000.000.000.000.000.000.00
Free Cash Flow -10.00-5.000.000.000.000.000.000.001.000.000.000.00
CFO/OP % -173.00274.0028.00100.0072.00167.00100.00138.0010.0073.0067.00-38.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 279.00โ€”โ€”โ€”โ€”โ€”โ€”-11,406.00254.00141.00204.00198.00
Inventory Days 0.00โ€”โ€”โ€”โ€”โ€”โ€”0.000.0017.0016.0026.00
Days Payable โ€”โ€”โ€”โ€”โ€”โ€”โ€”โ€”โ€”97.00140.00130.00
Cash Conversion Cycle 279.00โ€”โ€”โ€”โ€”โ€”โ€”-11,406.00254.0061.0080.0094.00
Working Capital Days 66.00โ€”โ€”โ€”โ€”โ€”โ€”-912.00-28.0034.0070.0086.00
ROCE % 21.00-8.00-43.00-53.00-29.00-27.00-9.00-19.00-44.007.004.004.00

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Public 100.00 100.00 100.00 100.00 100.01 100.00 100.00 100.01 100.01 100.01 100.01 100.01
No. of Shareholders 9,680 9,185 8,862 8,098 7,449 7,435 7,343 7,367 7,336 7,364 7,396 7,415

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Other 13 Sep 2006 โ€” โ€” โ€” General

Announcements

5 filings